safety Archives - Page 3 of 10 -

Teva expands blood pressure drug recall in the US amid cancer fears

https://pharmaphorum.com/news/teva-expands-blood-pressure-drug-recall-in-the-us-amid-cancer-fears/

Lilly moves Crohn’s drug into phase 3, faces safety setback in Japan

https://pharmaphorum.com/news/lilly-moves-crohns-drug-mirikizumab/

EU regulators slap safety restriction on Pfizer’s Xeljanz

https://pharmaphorum.com/news/eu-regulators-slap-safety-restriction-on-pfizers-xeljanz/

European regulator restricts use of Sanofi MS drug Lemtrada

https://pharmaphorum.com/news/european-regulator-restricts-use-of-sanofi-ms-drug-lemtrada/

Bayer and J&J settle Xarelto lawsuits in US

https://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/

Acadia faces US federal probe into Nuplazid marketing

https://pharmaphorum.com/news/acadia-faces-us-federal-probe-into-nuplazid-marketing/

Patients switch to lower dose of Pfizer’s RA pill after safety signal

https://pharmaphorum.com/news/patients-switch-to-lower-dose-of-pfizers-ra-pill-after-safety-signal/

FDA panel backs J&J’s potential depression blockbuster

https://pharmaphorum.com/news/fda-panel-backs-jjs-potential-depression-blockbuster/

FDA rejects Allergan’s fibroids drug, citing liver safety concerns

https://pharmaphorum.com/news/fda-rejects-allergans-fibroids-drug-citing-liver-safety-concerns/

Search